Nothing Special   »   [go: up one dir, main page]

NO940736L - DNA sekvenser som koder for gelonin polypeptid - Google Patents

DNA sekvenser som koder for gelonin polypeptid

Info

Publication number
NO940736L
NO940736L NO940736A NO940736A NO940736L NO 940736 L NO940736 L NO 940736L NO 940736 A NO940736 A NO 940736A NO 940736 A NO940736 A NO 940736A NO 940736 L NO940736 L NO 940736L
Authority
NO
Norway
Prior art keywords
dna sequences
gelonin
sequences encoding
synthetic gene
encoding gelonin
Prior art date
Application number
NO940736A
Other languages
English (en)
Other versions
NO317659B1 (no
NO940736D0 (no
Inventor
Michael G Rosenblum
Kenneth L Beattie
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of NO940736D0 publication Critical patent/NO940736D0/no
Publication of NO940736L publication Critical patent/NO940736L/no
Publication of NO317659B1 publication Critical patent/NO317659B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
NO19940736A 1991-09-06 1994-03-03 Syntetisk DNA som koder for gelonin-polypeptid, fremgangsmate for fremstilling av dette, samt en vertscelle som inneholder en ekspresjonsvektor omfattende nevnte syntetiske DNA NO317659B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75594991A 1991-09-06 1991-09-06
PCT/US1992/007066 WO1993005168A1 (en) 1991-09-06 1992-08-21 Dna sequences encoding gelonin polypeptide

Publications (3)

Publication Number Publication Date
NO940736D0 NO940736D0 (no) 1994-03-03
NO940736L true NO940736L (no) 1994-03-03
NO317659B1 NO317659B1 (no) 2004-11-29

Family

ID=25041367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19940736A NO317659B1 (no) 1991-09-06 1994-03-03 Syntetisk DNA som koder for gelonin-polypeptid, fremgangsmate for fremstilling av dette, samt en vertscelle som inneholder en ekspresjonsvektor omfattende nevnte syntetiske DNA

Country Status (18)

Country Link
US (1) US5624827A (no)
EP (1) EP0602144B1 (no)
JP (1) JPH06510431A (no)
KR (1) KR100270195B1 (no)
CN (1) CN1047402C (no)
AT (1) ATE173023T1 (no)
AU (1) AU679427B2 (no)
CA (1) CA2115049C (no)
DE (1) DE69227519T2 (no)
DK (1) DK0602144T3 (no)
ES (1) ES2123008T3 (no)
FI (1) FI113547B (no)
IL (1) IL103057A (no)
NO (1) NO317659B1 (no)
NZ (1) NZ244220A (no)
RU (1) RU2142015C1 (no)
WO (1) WO1993005168A1 (no)
ZA (1) ZA926705B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317009A (en) * 1991-08-26 1994-05-31 New York University Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
US5621083A (en) 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US6146850A (en) 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
WO1994026910A1 (en) * 1993-05-12 1994-11-24 Xoma Corporation Immunotoxins comprising gelonin and an antibody
CA2507749C (en) * 1991-12-13 2010-08-24 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
US5869619A (en) * 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
US20030166169A1 (en) * 1998-01-16 2003-09-04 Padgett Hal S. Method for constructing viral nucleic acids in a cell-free manner
ZA200305980B (en) 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
NZ530582A (en) * 2001-07-17 2008-06-30 Res Dev Foundation Therapeutic agents comprising pro-apoptotic proteins, including granzyme, bax and TNF
AU2003275985A1 (en) * 2002-06-12 2003-12-31 Research Development Foundation Immunotoxin as a therapeutic agent and uses thereof
PT2891666T (pt) 2002-10-16 2017-09-22 Purdue Pharma Lp Anticorpos que se ligam ca 125/0722p associado a células e métodos para a sua utilização
CA2595904A1 (en) * 2005-02-01 2006-08-10 Research Development Foundation Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders
KR101224828B1 (ko) * 2009-05-14 2013-01-22 (주)바이오니아 ｓｉＲＮＡ 접합체 및 그 제조방법
US8759036B2 (en) 2011-03-21 2014-06-24 Affymetrix, Inc. Methods for synthesizing pools of probes
WO2014153188A2 (en) 2013-03-14 2014-09-25 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
EP2768607B1 (en) 2011-09-26 2021-08-18 Thermo Fisher Scientific GENEART GmbH Multiwell plate for high efficiency, small volume nucleic acid synthesis
EP2904004B1 (en) 2012-10-04 2018-11-21 Research Development Foundation Serine protease molecules and therapies
CA2970477C (en) 2014-12-09 2022-03-15 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
US20180291413A1 (en) 2015-10-06 2018-10-11 Thermo Fisher Scientific Geneart Gmbh Devices and methods for producing nucleic acids and proteins
US20210147830A1 (en) 2018-06-29 2021-05-20 Thermo Fisher Scientific Geneart Gmbh High throughput assembly of nucleic acid molecules
GB201905303D0 (en) 2019-04-15 2019-05-29 Thermo Fisher Scient Geneart Gmbh Multiplex assembly of nucleic acid molecules
JP2023516827A (ja) 2020-03-06 2023-04-20 ライフ テクノロジーズ コーポレイション 高配列忠実度の核酸合成およびアセンブリ
WO2024132094A1 (en) 2022-12-19 2024-06-27 Thermo Fisher Scientific Geneart Gmbh Retrieval of sequence-verified nucleic acid molecules
GB2628173A (en) 2023-03-17 2024-09-18 Thermo Fisher Scient Geneart Gmbh Methods of producing modified nucleic acid sequences for eliminating adverse splicing events

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888415A (en) * 1985-03-04 1989-12-19 Dana-Farber Cancer Institute, Inc. Gelonin immunotoxin
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
US5290914A (en) * 1988-04-28 1994-03-01 Mycogen Corporation Hybrid diphtheria-B.t. pesticidal toxins
IE912716A1 (en) * 1990-08-14 1992-02-26 Res Dev Foundation Protein Structure of the Plant Toxin Gelonin

Also Published As

Publication number Publication date
RU94034733A (ru) 1996-06-10
WO1993005168A1 (en) 1993-03-18
ES2123008T3 (es) 1999-01-01
NO317659B1 (no) 2004-11-29
NO940736D0 (no) 1994-03-03
DK0602144T3 (da) 1999-07-19
NZ244220A (en) 1994-12-22
CN1047402C (zh) 1999-12-15
CA2115049A1 (en) 1993-03-18
DE69227519D1 (de) 1998-12-10
DE69227519T2 (de) 1999-06-02
ZA926705B (en) 1993-04-28
KR100270195B1 (ko) 2001-03-02
IL103057A (en) 1999-09-22
AU679427B2 (en) 1997-07-03
US5624827A (en) 1997-04-29
AU2547692A (en) 1993-04-05
CN1070227A (zh) 1993-03-24
JPH06510431A (ja) 1994-11-24
RU2142015C1 (ru) 1999-11-27
ATE173023T1 (de) 1998-11-15
FI941048A (fi) 1994-03-04
FI941048A0 (fi) 1994-03-04
EP0602144A1 (en) 1994-06-22
CA2115049C (en) 2003-10-21
EP0602144B1 (en) 1998-11-04
IL103057A0 (en) 1993-02-21
EP0602144A4 (en) 1995-03-15
FI113547B (fi) 2004-05-14

Similar Documents

Publication Publication Date Title
NO940736L (no) DNA sekvenser som koder for gelonin polypeptid
IL86480A0 (en) Recombinant dna coding for human proapolipoprotein a-i,expression vectors containing it and cells transformed by said expression vector
AR248044A1 (es) Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
AU8635391A (en) Nucleotide sequences coding for a human protein with angiogenesis regulative properties
DE69434292D1 (de) Für adseverin kodierendes gen
NZ241829A (en) Oxalate oxidase, genes encoding it, vectors and transformed plants
ZA916171B (en) Protein structure of the plant toxin gelonin
DE69634918D1 (de) Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie
FI961202A (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees